Down Syndrome: Clinical Trials

433 trials for Down Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

246 completed, 73 recruiting, 46 unknown, 23 terminated. 217 Not applicable, 39 Phase 2, 17 Phase 3, 16 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable217Completed 138, Recruiting 38, Unknown 17, Not yet recruiting 10, Active not recruiting 6, Terminated 5, Enrolling by invitation 3
Phase 239Completed 19, Recruiting 10, Withdrawn 3, Active not recruiting 2, Terminated 2, Unknown 2, Not yet recruiting 1
Phase 317Completed 5, Recruiting 5, Terminated 4, Active not recruiting 2, Unknown 1
Phase 116Completed 11, Not yet recruiting 2, Enrolling by invitation 1, Recruiting 1, Terminated 1
Phase 46Completed 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1

Follow Down Syndrome: new trials by email Literature Review of Down Syndrome trials Research Report on Down Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of a Pacifier on Obstructive Sleep Apnea and Its Repercussions in Infants With Down Syndrome
CURAPROX pacifier use, Pacifier diary, Polysomnography (PSG) to explore OSA - Obstructive Sleep Apnea, Down Syndrome (Trisomy 21)
Not applicableNot yet recruitingHospices Civils de Lyon502026-11-022026-10-07
Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance
EMPOWER-ND - Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD)
Not applicableNot yet recruitingBoston University Charles River Campus502026-11-012026-10-27
Escalating Doses of Memantine in Down Syndrome (MEDS-123)
Memantine - Down Syndrome, Intellectual Disability
Phase 1Not yet recruitingUniversity Hospitals Cleveland Medical Center252026-10-142026-10-05
An Open-Label Phase II Feasibility Study for the Use of Ublituximab in Adults With Down Syndrome Regression Disorder
Ublituximab - Down Syndrome Regression Disorder (DSRD), Down Syndrome (Trisomy 21)
Phase 2Not yet recruitingJonathan Santoro202026-10-012026-09-23
Hematological Profile in Children With Numerical Chromosomal Disorders
Down Syndrome, Turner Syndrome
Not yet recruitingAssiut University1582026-09-022026-09-10
Vestibular Stimulation Versus Foot Intrinsic Muscle Exercises in Children With Down Syndrome
Vestibular Stimulation Exercises, Foot Intrinsic Muscle Exercises - Down Syndrome, Balance Impairment
Not applicableNot yet recruitingShalamar Institute of Health Sciences482026-09-022026-08-21
Pilot Evaluation of the Developed Syntactic-Semantic Visual Configuration Intervention for Children With Language Impairment
Syntactic-Semantic Visual Configuration Intervention (SSVCI) - Language Impairment, Autism
Not applicableNot yet recruitingRiphah International University202026-09-012026-08-26
Executive Function Play Opportunities for Children With Down Syndrome
EXPO, EXPO Extended, EXPO Foundations - Down Syndrome, Trisomy 21
Not applicableNot yet recruitingColorado State University1502026-09-012026-08-28
Home and Community Use of a Suspension Walker in Pre-Walking Infants With Down Syndrome
suspension walker - Down Syndrome
Not applicableNot yet recruitingUniversity of Southern California122026-09-012026-06-05
NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
MIB-626, Placebo - Down Syndrome (DS)
Phase 1Not yet recruitingBrigham and Women's Hospital242026-08-312026-08-19
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Mivelsiran, Placebo - Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Phase 2RecruitingAlnylam Pharmaceuticals582026-08-172026-10-13
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Donanemab, Placebo - Down Syndrome (DS), Down Syndrome (Trisomy 21)
Phase 4Not yet recruitingMichael Rafii, MD, PhD602026-08-012026-05-15
The Neurocognitive Bases of Trust in Intellectual Disability
Confidence adjustment assessment, clinical assessment, Cognitive assessment - Down Syndrome (Trisomy 21), Fragile X Syndrome (FXS)
RecruitingHospices Civils de Lyon1122026-07-172026-08-05
Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome
Metric-optimized spectacles, Routine Clinical Spectacles - Refractive Error Correction, Visual Acuity
Phase 2RecruitingOhio State University242026-07-132026-07-20
Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
Down Syndrome
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)7002026-06-232026-10-19
Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1
Tofacitinib Oral Solution, Placebo - Down Syndrome
Phase 2RecruitingUniversity of Colorado, Denver922026-05-282026-09-03
Collaboration for Down Syndrome Progress (CDP)
Down Syndrome, Chromosome Disorders
RecruitingRTI International14002026-05-012026-06-04
HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome
The HomeGrown, Waitlist - Down Syndrome, Child Obesity
Not applicableActive not recruitingUNC Lineberger Comprehensive Cancer Center382026-04-162026-09-03
Vascular Function in Adults With Down Syndrome
Down Syndrome (Trisomy 21)
RecruitingUniversity of Nevada, Las Vegas462026-04-092026-10-02
Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome
Cold Stress, Maximal Dynamic Exercise, Isometric Handgrip Exercise with Post-Exercise Muscle Ischemia - Down Syndrome, Autonomic Dysfunction
Phase 3RecruitingUniversity of Colorado, Denver2002026-04-062026-10-13

Showing 20 of 433. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (30)  ·  Sleep Apnea, Obstructive (27)  ·  Trisomy 18 Syndrome (27)  ·  Trisomy 13 Syndrome (24)  ·  Intellectual Disability (19)  ·  Cerebral Palsy (18)  ·  Motor Activity (16)  ·  Aneuploidy (15)  ·  Autism Spectrum Disorder (14)  ·  Turner Syndrome (14)  ·  Cognitive Dysfunction (12)  ·  Developmental Disabilities (10)  ·  Fragile X Syndrome (9)  ·  Autistic Disorder (8)

Broader conditions

Abnormalities, Multiple (433)  ·  Neurobehavioral Manifestations (433)  ·  Congenital Abnormalities (432)  ·  Neurologic Manifestations (432)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (431)  ·  Genetic Diseases, Inborn (431)  ·  Nervous System Diseases (431)  ·  Chromosome Disorders (430)  ·  Intellectual Disability (414)  ·  Pathological Conditions, Signs and Symptoms (88)  ·  Mental Disorders (85)  ·  Signs and Symptoms (56)  ·  Central Nervous System Diseases (54)  ·  Brain Diseases (51)  ·  Behavior (44)

Interventions

Blood Specimen Collection (6)  ·  Cytarabine (6)  ·  Exercise (5)  ·  Leucovorin (5)  ·  Control Groups (4)  ·  Dexamethasone (4)  ·  Donepezil (4)  ·  Memantine (4)  ·  Mercaptopurine (4)  ·  Methotrexate (4)  ·  Polysomnography (4)  ·  Vincristine (4)  ·  Asparaginase (3)  ·  Atomoxetine Hydrochloride (3)  ·  Calcium Dobesilate (3)

Sponsors

Riphah International University (48)  ·  Cairo University (12)  ·  University of Colorado, Denver (12)  ·  Institut Jerome Lejeune (10)  ·  Natera, Inc. (8)  ·  Sequenom, Inc. (8)  ·  University of Kansas Medical Center (8)  ·  University of Sao Paulo (8)  ·  Children's Hospital Medical Center, Cincinnati (7)  ·  Hoffmann-La Roche (7)  ·  Oregon Health and Science University (5)  ·  Parc de Salut Mar (5)  ·  University of Michigan (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Children's Hospital of Philadelphia (4)

Countries

United States (201)  ·  Pakistan (50)  ·  France (39)  ·  Spain (36)  ·  Canada (22)  ·  Egypt (21)  ·  Turkey (Türkiye) (19)  ·  United Kingdom (15)  ·  Italy (14)  ·  Australia (8)  ·  Brazil (8)  ·  Ireland (8)  ·  Saudi Arabia (6)  ·  Belgium (5)  ·  Mexico (5)

Top investigators

Joaquin Espinosa, PhD (4)  ·  Michael S. Rafii, MD, PhD (3)  ·  Richard Porreco, MD (3)  ·  Suelly CO Limongi, PhD (3)  ·  Alberto C Costa, MD, PhD (2)  ·  Amy Bodde, PhD (2)  ·  Amy J Sehnert, MD (2)  ·  Andrea Kelly, MD, MSCE (2)  ·  Anna Esbensen, PhD (2)  ·  Binash Afzal, PHD* (2)  ·  Brian Chicoine, MD (2)  ·  Daniel Combs, MD (2)  ·  Glenn E Palomaki, PhD (2)  ·  Michael Rafii, MD, PhD (2)

Results publications

PMID 22005709, PMID 22281937, PMID 25834952, PMID 10417280, PMID 10586155, PMID 12820840, PMID 12889762, PMID 16814942, PMID 17344250, PMID 18296460, PMID 19104360, PMID 20075148, PMID 20084109, PMID 20097432, PMID 20375405, PMID 20673078, PMID 20927000, PMID 21310373, PMID 21352207, PMID 21519036, PMID 21829931, PMID 21950393, PMID 22247403, PMID 22362253, PMID 22464072, PMID 22585317, PMID 22617594, PMID 22742782, PMID 22806212, PMID 22940168, PMID 23072851, PMID 23215555, PMID 23521658, PMID 23555282, PMID 23592541, PMID 23592550, PMID 23613152, PMID 23635743, PMID 23712453, PMID 23968742, PMID 24091801, PMID 24135152, PMID 24360805, PMID 24388429, PMID 24408338, PMID 24571752, PMID 24785862, PMID 24831720, PMID 25004354, PMID 25111587

NIH funding

U10CA180886 (4), 2023 (2), 2025 (2), R01AG016381 (2), R01HD071981 (2), R61HL151253 (2), 3KL2TR002367-08S1 (1), 5TL1TR002318-07 (1), K12HD055931 (1), K23MH077554 (1), K99HD092606 (1), KL2TR002367 (1), OT2HD117033 (1), R00HD092606 (1), R01AG031110 (1)